MX2021011303A - Nueva linea celular que comprende marcador de seleccion y usos de la misma para la produccion de proteinas. - Google Patents

Nueva linea celular que comprende marcador de seleccion y usos de la misma para la produccion de proteinas.

Info

Publication number
MX2021011303A
MX2021011303A MX2021011303A MX2021011303A MX2021011303A MX 2021011303 A MX2021011303 A MX 2021011303A MX 2021011303 A MX2021011303 A MX 2021011303A MX 2021011303 A MX2021011303 A MX 2021011303A MX 2021011303 A MX2021011303 A MX 2021011303A
Authority
MX
Mexico
Prior art keywords
production
cell line
proteins
selection marker
line includes
Prior art date
Application number
MX2021011303A
Other languages
English (en)
Spanish (es)
Inventor
Bruno Louis Dumas
Mohammed Nabil Lounis
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX2021011303A publication Critical patent/MX2021011303A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/05—Oxidoreductases acting on the CH-CH group of donors (1.3) with a quinone or related compound as acceptor (1.3.5)
    • C12Y103/05002—Dihydroorotate dehydrogenase (1.3.5.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
MX2021011303A 2019-03-19 2020-03-19 Nueva linea celular que comprende marcador de seleccion y usos de la misma para la produccion de proteinas. MX2021011303A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19305331 2019-03-19
PCT/EP2020/057583 WO2020188021A1 (en) 2019-03-19 2020-03-19 Novel selection marker-comprising cell line and uses thereof for protein production

Publications (1)

Publication Number Publication Date
MX2021011303A true MX2021011303A (es) 2021-10-22

Family

ID=66001151

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021011303A MX2021011303A (es) 2019-03-19 2020-03-19 Nueva linea celular que comprende marcador de seleccion y usos de la misma para la produccion de proteinas.

Country Status (14)

Country Link
US (1) US12529071B2 (cg-RX-API-DMAC7.html)
EP (1) EP3942054A1 (cg-RX-API-DMAC7.html)
JP (1) JP7609795B2 (cg-RX-API-DMAC7.html)
KR (1) KR102976749B1 (cg-RX-API-DMAC7.html)
CN (1) CN113811615B (cg-RX-API-DMAC7.html)
AU (1) AU2020242966B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021018124A2 (cg-RX-API-DMAC7.html)
CA (1) CA3134116A1 (cg-RX-API-DMAC7.html)
IL (1) IL286419A (cg-RX-API-DMAC7.html)
MX (1) MX2021011303A (cg-RX-API-DMAC7.html)
SG (1) SG11202110105UA (cg-RX-API-DMAC7.html)
TW (1) TWI881970B (cg-RX-API-DMAC7.html)
WO (1) WO2020188021A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202106718B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI912369B (zh) * 2020-09-21 2026-01-21 法商賽諾菲公司 用於生產治療蛋白之高生產重組中國倉鼠卵巢細胞株之世代

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
KR100267720B1 (ko) 1997-12-29 2001-03-02 박호군 사람 글루타민 합성효소 유전자를 포함하는 발현벡터 및 이를 이용하여 동물세포에서 에리트로포이에틴을 고수율로 생산하는 방법
US20030166201A1 (en) * 2001-04-30 2003-09-04 Jensen Michael C. Selection systems for genetically modified cells
EP2022855B1 (en) 2006-05-16 2015-08-19 Daiichi Sankyo Company, Limited High secretion production method of protein
WO2012027533A1 (en) * 2010-08-25 2012-03-01 Gt Life Sciences, Inc. Selectable markers and related methods
RU2556816C1 (ru) 2014-03-12 2015-07-20 Открытое акционерное общество "Фармацевтический импорт, экспорт" (ОАО "Фармимэкс") Штамм клеток яичников китайского хомячка - продуцент рекомбинантного антитела против фактора некроза опухоли альфа человека
CA2965202C (en) * 2014-10-23 2023-02-28 Sanofi Novel selection marker for cell transfection and protein production
EP3344243B1 (en) * 2015-09-01 2020-12-09 The Broad Institute, Inc. Compounds and methods useful for treating or preventing hematological cancers
WO2017117006A1 (en) * 2015-12-29 2017-07-06 The Board Of Trustees Of The Leland Stanford Junior University Use of a dhodh inhibitor in combination with an inhibitor of pyrimidine salvage
CN109777837A (zh) 2018-12-26 2019-05-21 首都医科大学 一种利用CRISPR/Cas9系统构建致死基因全身性敲除小鼠模型的方法
TWI912369B (zh) 2020-09-21 2026-01-21 法商賽諾菲公司 用於生產治療蛋白之高生產重組中國倉鼠卵巢細胞株之世代

Also Published As

Publication number Publication date
CN113811615B (zh) 2025-11-11
CA3134116A1 (en) 2020-09-24
IL286419A (en) 2021-10-31
AU2020242966A1 (en) 2021-10-21
ZA202106718B (en) 2023-04-26
US12529071B2 (en) 2026-01-20
BR112021018124A2 (pt) 2021-11-16
AU2020242966B2 (en) 2025-09-25
US20220177909A1 (en) 2022-06-09
JP7609795B2 (ja) 2025-01-07
EP3942054A1 (en) 2022-01-26
SG11202110105UA (en) 2021-10-28
CN113811615A (zh) 2021-12-17
TW202102669A (zh) 2021-01-16
TWI881970B (zh) 2025-05-01
KR102976749B1 (ko) 2026-06-15
WO2020188021A1 (en) 2020-09-24
KR20210141511A (ko) 2021-11-23
JP2022526497A (ja) 2022-05-25

Similar Documents

Publication Publication Date Title
CL2022001670A1 (es) Inhibidores de proteínas kras mutantes
CL2021000704A1 (es) Anticuerpos contra proteína alfa reguladora de señal y métodos de uso. (divisional de solicitud 668-2019)
MX390940B (es) Medio de cultivo celular complementado con taurina y metodos de uso.
CL2020001451A1 (es) Proteínas modificadas de unión a adn.
CO2021002907A2 (es) Constructos de anticuerpos para cldn18.2 y cd3
MX2020004145A (es) Variantes de desoxirribonucleasa (dnasa).
CL2023002358A1 (es) Constructos de arni para inhibir la expresión de pnpla3 y sus métodos de uso
MX2019008755A (es) Variantes de hsd17b13 y usos de las mismas.
PE20190563A1 (es) Genes de mini-distrofina optimizados y casetes de expresion y su uso
TWD199998S (zh) 飾品
PE20181156A1 (es) Genes de ataxia de friedreich modificados y vectores para terapia genica
BR112018074979A2 (pt) composições de limpeza que compreendem enzimas
CR20220618A (es) Nuevas proteinas de unión a repeticiones de anquirina y sus usos
ECSP21081726A (es) Inhibidores de dihidroorotato deshidrogenasa
WO2015176066A3 (en) Lpa-associated protein and rna expression
CO2021008997A2 (es) Constructos de arni para inhibir la expresión de pnpla3 y métodos de uso de estos
MX2021002250A (es) Dominio de nucleasa novedoso y uso del mismo.
BR112022002942A2 (pt) Composição enzimática
IL286928A (en) Interleukin-4–induced gene 1 (il4i1) as a biomarker and uses thereof
CR20200404A (es) Anticuerpos anti-klk5 y métodos de uso
MX2019009759A (es) Composiciones de peptido estables.
CL2024002358A1 (es) Variante de fitasa; método de producción; composición; y su uso.
CO2024015896A2 (es) Inhibidores de mek y usos de estos
AR123756A1 (es) Construcciones de ácidos nucléicos, vectores virales y partículas virales
BR112021018124A2 (pt) Linhagem celular compreendendo marcador de seleção e usos do mesmo para produção de proteína